Association between triallelic polymorphism of the serotonin transporter and [18F]MPPF binding potential at 5-HT1A receptors in healthy subjects

NeuroImage

Volumn 47, Issue 2, 2009, Pages 482-492

  Lothe, Amélie ^a,b   Boni, Claudette ^c   Costes, Nicolas ^d   Gorwood, Philip ^c   Bouvard, Sandrine ^a   Le Bars, Didier ^d   Lavenne, Franck ^d   Ryvlin, Philippe ^a,b,e  

^a CTRS IDEE   (France)

^b UNIVERSITÉ LYON 1   (France)

^c INSERM   (France)

^d CERMEP IMAGERIE DU VIVANT   (France)

^e HOSPICES CIVILS DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 (2' METHOXYPHENYL) 1 [2' (N 2 PIRYDYNYL) P FLUOROBENZAMIDO] ETHYL PIPERAZINE F 18; RADIOPHARMACEUTICAL AGENT; SEROTONIN 1A RECEPTOR; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BINDING AFFINITY; CINGULATE GYRUS; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOTE; HUMAN; HUMAN CELL; MALE; MUTATIONAL ANALYSIS; ORBITAL CORTEX; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAPHE NUCLEUS; RECEPTOR BINDING; RECEPTOR DENSITY; RECEPTOR OCCUPANCY; SEX DIFFERENCE; SUPRASYLVIAN GYRUS; TEMPORAL LOBE;

ADULT; BRAIN; FEMALE; GENE FREQUENCY; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; POLYMORPHISM, SINGLE NUCLEOTIDE; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; PYRIDINES; RADIOPHARMACEUTICALS; RECEPTOR, SEROTONIN, 5-HT1A; TISSUE DISTRIBUTION;

EID: 67449135858     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2009.04.067     Document Type: Article

References (85)

1. Alessandro S., and Kato M. The serotonin transporter gene and effectiveness of SSRIs. Expert Rev. Neurotherapeutics 8 1 (2008) 111-120
2. Bah J., Lindström M., Westberg L., Mannerås L., Ryding E., Henningsson S., Melke J., Rosén I., Träskman-Bendz L., and Eriksson E. Serotonin transporter gene polymorphisms: effect on serotonin transporter availability in the brain of suicide attempters. Psychiatry Res. 162 3 (2008) 221-229
3. Barnes N.M., and Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology 38 8 (1999) 1083-1152
4. Blakely R.D., De Felice L.J., and Hartzell H.C. Molecular physiology of norepinephrine and serotonin transporters. J. Exp. Biol. 196 (1994) 263-281
5. Borg J., Henningsson S., Saijo T., Inoue M., Bah J., Westberg L., Lundberg J., Jovanovic H., Andrée B., Nordstrom A.L., Halldin C., Eriksson E., and Farde L. Serotonin transporter genotype is associated with cognitive performance but not regional 5-HT1A receptor binding in humans. Int. J. Neuropsychopharmacol. (2009) 1-10
6. Buhot M.C., Martin S., and Segu L. Role of serotonin in memory impairment. Ann. Med. 32 3 (2000) 210-221
7. Burgess N.K., Sweeten T.L., McMahon W.M., and Fujinami R.S. Hyperserotoninemia and altered immunity in autism. J. Autism. Dev. Disord. 36 5 (2006) 697-704
8. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., McClay J., Mill J., Martin J., Braithwaite A., and Poulton R. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301 5631 (2003) 386-389
9. Chugani D.C. Serotonin in autism and pediatric epilepsies. Ment. Retard. Dev. Disabil. Res. Rev. 10 2 (2004) 112-116
10. Cidis Meltzer C., Drevets W.C., Price J.C., Mathis C.A., Lopresti B., Greer P.J., Villemagne V.L., Holt D., Mason N.S., Houck P.R., Reynolds III C.F., and DeKosky S.T. Gender-specific aging effects on the serotonin 1A receptor. Brain Res.23 895 1-2 (2001) 9-17
11. Costes N., Merlet I., Zimmer L., Lavenne F., Cinotti L., Delforge J., Luxen A., Pujol J.F., and Le Bars D. Modeling [18F]MPPF positron emission tomography kinetics for the determination of 5-hydroxytryptamine(1A) receptor concentration with multiinjection. J. Cereb. Blood Flow Metab. 22 6 (2002) 753-765
12. 18F-MPPF PET normative database of 5-HT1A receptor binding in men and women over aging. J. Nucl. Med. 46 12 (2005) 1980-1989
13. Costes N., Benkelfat C., Zimmer L., Dagher A., and Le Bars D. Toward a quantification of extra-cellular brain endogenous serotonin concentration with [18F]MPPF in PET and a multi-injection protocol; NeuroReceptor Mapping 08, Pittsburg. NeuroImage (2008) T149
14. Dannlowski U., Ohrmann P., Bauer J., Kugel H., Baune B.T., Hohoff C., Kersting A., Arolt V., Heindel W., Deckert J., and Suslow T. Serotonergic genes modulate amygdala activity in major depression. Genes Brain Behav. 6 7 (2007) 672-676
15. David S.P., Murthy N.V., Rabiner E.A., Munafó M.R., Johnstone E.C., Jacob R., Walton R.T., and Grasby P.M. A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans. J. Neurosci. 25 10 (2005) 2586-2590
16. Didelot A., Ryvlin P., Lothe A., Merlet I., Hammers A., and Mauguiere F. PET imaging of brain 5-HT1A receptors in the preoperative evaluation of temporal lobe epilepsy. Brain 131 Pt 10 (2008) 2751-2764
17. Drevets W.C., Thase M.E., Moses-Kolko E.L., Price J., Frank E., Kupfer D.J., and Mathis C. Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl. Med. Biol. 34 7 (2007) 865-877
18. Fabre V., Beaufour C., Evrard A., Rioux A., Hanoun N., Lesch K.P., Murphy D.L., Lanfumey L., Hamon M., and Martres M.P. Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter. Eur. J. Neurosci. 12 7 (2000) 2299-2310
19. Friston K.J., Frith C.D., Liddle P.F., and Frackowiak R.S.J. Comparing functional (PET) images: the assessment of significant changes. J. Cereb. Blood Flow Metab. 11 4 (1991) 690-699
20. Friston K.J., Holmes A.P., Worsley K.J., Poline J.B., Frith C.D., and Frackowiak R.J.S. Statistical parametric maps in functional imaging: a general linear approach. Hum. Brain Mapp. 3 (1995) 189-210
21. Gotlib I.H., Joormann J., Minor K.L., and Hallmayer J. HPA axis reactivity: a mechanism underlying the associations among 5-HTTLPR, stress, and depression. Biol. Psychiatry 63 9 (2008) 847-851
22. Graff-Guerrero A., De la Fuente-Sandoval C., Camarena B., Gómez-Martin D., Apiquián R., Fresán A., Aguilar A., Méndez-Núñez J.C., Escalona-Huerta C., Drucker-Colín R., and Nicolini H. Frontal and limbic metabolic differences in subjects selected according to genetic variation of the SLC6A4 gene polymorphism. NeuroImage 25 4 (2005) 1197-1204
23. Gross C., Zhuang X., Stark K., Ramboz S., Oosting R., Kirby L., Santarelli L., Beck S., and Hen R. Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 416 6879 (2002) 396-400
24. Gunn R.N., Sargent P.A., Bench C.J., Rabiner E.A., Osman S., Pike V.W., Hume S.P., Grasby P.M., and Lammertsma A.A. Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PET. NeuroImage 8 4 (1998) 426-440
25. Hainer V., Kabrnova K., Aldhoon B., Kunesova M., and Wagenknecht M. Serotonin and norepinephrine reuptake inhibition and eating behavior. Ann. N. Y. Acad. Sci. 1083 (2006) 252-269 Review
26. Hall H., Lundkvist C., Halldin C., Farde L., Pike V.W., McCarron J.A., Fletcher A., Cliffe I.A., Barf T., Wikström H., and Sedvall G. Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635. Brain Res. 745 1-2 (1997) 96-108
27. Hariri A.R., Tessitore A., Mattay V.S., Fera F., and Weinberger D.R. The amygdala response to emotional stimuli: a comparison of faces and scenes. NeuroImage 17 1 (2002) 317-323
28. Heils A., Teufel A., Petri S., Stober G., Riederer P., Bengel D., and Lesch K.P. Allelic variation of human serotonin transporter gene expression. J. Neurochem. 66 6 (1996) 2621-2624
29. Heinz A., Jones D.W., Raedler T., Coppola R., Knable M.B., and Weinberger D.R. Neuropharmacological studies with SPECT in neuropsychiatric disorders. Nucl. Med. Biol. 27 7 (2000) 677-682 Review
30. Homberg J.R., Olivier J.D., Smits B.M., Mul J.D., Mudde J., Verheul M., Nieuwenhuizen O.F., Cools A.R., Ronken E., Cremers T., Schoffelmeer A.N., Ellenbroek B.A., and Cuppen E. Characterization of the serotonin transporter knockout rat: a selective change in the functioning of the serotonergic system. Neuroscience 146 4 (2007) 1662-1676
31. Hu X.Z., Lipsky R.H., Zhu G., Akhtar L.A., Taubman J., Greenberg B.D., Xu K., Arnold P.D., Richter M.A., Kennedy J.L., Murphy D.L., and Goldman D. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am. J. Hum. Genet. 78 5 (2006) 815-826
32. Innis R.B., Cunningham V.J., Delforge J., Fujita M., Gjedde A., Gunn R.N., Holden J., Houle S., Huang S.C., Ichise M., Iida H., Ito H., Kimura Y., Koeppe R.A., Knudsen G.M., Knuuti J., Lammertsma A.A., Laruelle M., Logan J., Maguire R.P., Mintun M.A., Morris E.D., Parsey R., Price J.C., Slifstein M., Sossi V., Suhara T., Votaw J.R., Wong D.F., and Carson R.E. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J. Cereb. Blood Flow Metab. 27 9 (2007) 1533-1539
33. Iqbal N., and van Praag H.M. The role of serotonin in schizophrenia. Eur Neuropsychopharmacol. 5 Suppl. (1995) 11-23 Review
34. Jacobsen L.K., Staley J.K., Malison R.T., Zoghbi S.S., Seibyl J.P., Kosten T.R., and Innis R.B. Elevated central serotonin transporter binding availability in acutely abstinent cocaine-dependent patients. Am. J. Psychiatry 157 7 (2000) 1134-1140
35. Jovanovic H., Lundberg J., Karlsson P., Cerin A., Saijo T., Varrone A., Halldin C., and Nordström A.L. Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET. NeuroImage 39 3 (2008) 1408-1419
36. Kendler K.S., Kuhn J.W., Vittum J., Prescott C.A., and Riley B. The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Arch. Gen. Psychiatry 62 5 (2005) 529-535
37. Kim D.K., Tolliver T.J., Huang S.J., Martin B.J., Andrews A.M., Wichems C., Holmes A., Lesch K.P., and Murphy D.L. Altered serotonin synthesis, turnover and dynamic regulation in multiple brain regions of mice lacking the serotonin transporter. Neuropharmacology 49 6 (2005) 798-810
38. Lee M., Bailer U.F., Frank G.K., Henry S.E., Meltzer C.C., Price J.C., Mathis C.A., Putnam K.T., Ferrell R.E., Hariri A.R., and Kaye W.H. Relationship of a 5-HT transporter functional polymorphism to 5-HT1A receptor binding in healthy women. Mol. Psychiatry 10 8 (2005) 715-716
39. Lesch K.P., and Mössner R. Genetically driven variation in serotonin uptake: is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders?. Biol. Psychiatry 44 3 (1998) 179-192
40. Lesch K.P., Bengel D., Heils A., Sabol S.Z., Greenberg B.D., Petri S., Benjamin J., Müller C.R., Hamer D.H., and Murphy D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274 5292 (1996) 1527-1531
41. Li Q., Wichems C., Heils A., Van De Kar L.D., Lesch K.P., and Murphy D.L. Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice. J. Pharmacol. Exp. Ther. 291 3 (1999) 999-1007
42. Li Q., Wichems C., Heils A., Lesch K.P., and Murphy D.L. Reduction in the density and expression, but not G-protein coupling, of serotonin receptors (5-HT1A) in 5-HT transporter knock-out mice: gender and brain region differences. J. Neurosci. 20 21 (2000) 7888-7895
43. Little K.Y., McLaughlin D.P., Zhang L., Livermore C.S., Dalack G.W., McFinton P.R., DelProposto Z.S., Hill E., Cassin B.J., Watson S.J., and Cook E.H. Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. Am. J. Psychiatry 155 2 (1998) 207-213
44. Lothe A., Merlet I., Demarquay G., Costes N., Ryvlin P., and Mauguière F. Interictal brain 5-HT(1A) receptors binding in migraine without aura: a (18)F-MPPF-PET study. Cephalalgia 28 12 (2008) 1282-1291
45. Lothe A., Didelot A., Hammers A., Costes N., Saoud M., Gilliam F., and Ryvlin P. Comorbidity between temporal lobe epilepsy and depression: a [18F]MPPF PET study. Brain 131 Pt 10 (2008) 2765-2782
46. Lucki I. The spectrum of behaviors influenced by serotonin. Biol. Psychiatry 44 (1998) 151-162
47. Lundberg J., Borg J., Halldin C., and Farde L. A PET study on regional coexpression of 5-HT1A receptors and 5-HTT in the human brain. Psychopharmacology (Berl). 195 3 (2007) 425-433
48. Maes M., and Meltzer H. The serotonin hypothesis of major depression. In: Bloom F.E., and Kupfer D.J. (Eds). Psychopharmacology. The Fourth Generation of Progress (1995), Raven Press Ltd, New York, NY 933-944
49. Mann J.J., Huang Y.Y., Underwood M.D., Kassir S.A., Oppenheim S., Kelly T.M., Dwork A.J., and Arango V. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch. Gen. Psychiatry 57 8 (2000) 729-738
50. Mathews T.A., Fedele D.E., Coppelli F.M., Avila A.M., Murphy D.L., and Andrews A.M. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression. J. Neurosci. Methods 140 1-2 (2004) 169-181
51. Mazziotta J., Toga A., Evans A., Fox P., Lancaster J., Zilles K., Woods R., Paus T., Simpson G., Pike B., Holmes C., Collins L., Thompson P., MacDonald D., Iacoboni M., Schormann T., Amunts K., Palomero-Gallagher N., Geyer S., Parsons L., Narr K., Kabani N., Le Goualher G., Boomsma D., Cannon T., Kawashima R., and Mazoyer B. A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). Philos. Trans. R. Soc. Lond. B Biol. Sci. 356 1412 (2001) 1293-1322
52. Merlet I., Ryvlin P., Costes N., Dufournel D., Isnard J., Faillenot I., Ostrowsky K., Lavenne F., Le Bars D., and Mauguière F. Statistical parametric mapping of 5-HT1A receptor binding in temporal lobe epilepsy with hippocampal ictal onset on intracranial EEG. NeuroImage 22 2 (2004) 886-896
53. Mizuno T., Aoki M., Shimada Y., Inoue M., Nakaya K., Takahashi T., Itoyama Y., Kanazawa M., Utsumi A., Endo Y., Nomura T., Hiratsuka M., Mizugaki M., Goto J., Hongo M., and Fukudo S. Gender difference in association between polymorphism of serotonin transporter gene regulatory region and anxiety. J. Psychosom. Res. 60 1 (2006) 91-97
54. Møller M., Jakobsen S., and Gjedde A. Parametric and regional maps of free serotonin 5HT1A receptor sites in human brain as function of age in healthy humans. Neuropsychopharmacology 32 8 (2007) 1707-1714
55. Murphy D.L., and Lesch K.P. Targeting the murine serotonin transporter: insights into human neurobiology. Nat. Rev., Neurosci. 9 2 (2008) 85-96 Review
56. Nakamura M., Ueno S., Sano A., and Tanabe H. The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol. Psychiatry 5 1 (2000) 32-38
57. Naylor L., Dean B., Pereira A., Mackinnon A., Kouzmenko A., and Copolov D. No association between the serotonin transporter-linked promoter region polymorphism and either schizophrenia or density of the serotonin transporter in human hippocampus. Mol. Med. 4 10 (1998) 671-674
58. Nishizawa S., Benkelfat C., Young S.N., Leyton M., Mzengeza S., de Montigny C., Blier P., and Diksic M. Differences between males and females in rates of serotonin synthesis in human brain. Proc. Natl. Acad. Sci. U. S. A. 94 10 (1997) 5308-5313
59. Parsey R.V., Oquendo M.A., Simpson N.R., Ogden R.T., Van Heertum R., Arango V., and Mann J.J. Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635. Brain Res. 954 2 (2002) 173-182
60. Parsey R.V., Arango V., Olvet M.D., Oquendo M.A., Van Heertum R.L., and Mann J.J. Regional heterogeneity of 5-HT1A receptors in human cerebellum as assessed by positron emission tomography. J. Cereb. Blood Flow Metab. 25 (2005) 785-793
61. Parsey R.V., Hastings R.S., Oquendo M.A., Hu X., Goldman D., Huang Y.Y., Simpson N., Arcement J., Huang Y., Ogden R.T., Van Heertum R.L., Arango V., and Mann J.J. Effect of a triallelic functional polymorphism of the serotonin-transporter-linked promoter region on expression of serotonin transporter in the human brain. Am. J. Psychiatry 163 1 (2006) 48-51
62. Patkar A.A., Berrettini W.H., Mannelli P., Gopalakrishnan R., Hoehe M.R., Bilal L., Weinstein S., and Vergare M.J. Relationship between serotonin transporter gene polymorphisms and platelet serotonin transporter sites among African-American cocaine-dependent individuals and healthy volunteers. Psychiatr. Genet. 14 1 (2004) 25-32
63. Praschak-Rieder N., Kennedy J., Wilson A.A., Hussey D., Boovariwala A., Willeit M., Ginovart N., Tharmalingam S., Masellis M., Houle S., and Meyer J.H. Novel 5-HTTLPR allele associates with higher serotonin transporter binding in putamen: a [(11)C] DASB positron emission tomography study. Biol. Psychiatry 62 4 (2007) 327-331
64. Rbah L., Leviel V., and Zimmer L. Displacement of the PET ligand 18F-MPPF by the electrically evoked serotonin release in the rat hippocampus. Synapse 49 4 (2003) 239-245
65. Reimold M., Smolka M.N., Schumann G., Zimmer A., Wrase J., Mann K., Hu X.Z., Goldman D., Reischl G., Solbach C., Machulla H.J., Bares R., and Heinz A. Midbrain serotonin transporter binding potential measured with [11C]DASB is affected by serotonin transporter genotype. J. Neural Transm. 114 5 (2007) 635-639
66. Reist C., Mazzanti C., Vu R., Tran D., and Goldman D. Serotonin transporter promoter polymorphism is associated with attenuated prolactin response to fenfluramine. Am. J. Med. Genet. 105 4 (2001) 363-368
67. Richer M., Hen R., and Blier P. Modification of serotonin neuron properties in mice lacking 5-HT1A receptors. Eur. J. Pharmacol. 435 2-3 (2002) 195-203
68. Rudnick G. Serotonin transporters-structure and function. J. Membr. Biol. 213 2 (2006) 101-110
69. Shioe K., Ichimiya T., Suhara T., Takano A., Sudo Y., Yasuno F., Hirano M., Shinohara M., Kagami M., Okubo Y., Nankai M., and Kanba S. No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET. Synapse 48 4 (2003) 184-188
70. Sibon I., Benkelfat C., Gravel P., Aznavour N., Costes N., Mzengeza S., Booij L., Baker G., Soucy J.P., Zimmer L., and Descarries L. Decreased [18F]MPPF binding potential in the dorsal raphe nucleus after a single oral dose of fluoxetine: a positron-emission tomography study in healthy volunteers. Biol. Psychiatry 63 12 (2008) 1135-1140
71. Smith G.S., Lotrich F.E., Malhotra A.K., Lee A.T., Ma Y., Kramer E., Gregersen P.K., Eidelberg D., and Pollock B.G. Effects of serotonin transporter promoter polymorphisms on serotonin function. Neuropsychopharmacology 29 12 (2004) 2226-2234
72. Tauscher J., Verhoeff N.P., Christensen B.K., Hussey D., Meyer J.H., Kecojevic A., Javanmard M., Kasper S., and Kapur S. Serotonin 5-HT1A receptor binding potential declines with age as measured by [11C]WAY-100635 and PET. Neuropsychopharmacology 24 5 (2001) 522-530
73. Truchot L., Costes N., Zimmer L., Laurent B., Le Bars D., Thomas-Antérion C., Mercier B., Hermier M., Vighetto A., and Krolak-Salmon P. A distinct [18F]MPPF PET profile in amnestic mild cognitive impairment compared to mild Alzheimer's disease. NeuroImage 40 3 (2008) 1251-1256
74. Varnäs K., Halldin C., and Hall H. Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain. Hum. Brain Mapp. 22 3 (2004) 246-260
75. Van Wijngaarden I., Tulp M.T., and Soudijn W. The concept of selectivity in 5-HT receptor research. Eur. J. Pharmacol. 188 6 (1990) 301-312
76. Walderhaug E., Magnusson A., Neumeister A., Lappalainen J., Lunde H., Refsum H., and Landrø N.I. Interactive effects of sex and 5-HTTLPR on mood and impulsivity during tryptophan depletion in healthy people. Biol. Psychiatry 62 6 (2007) 593-599
77. Weissmann-Nanopoulos D., Mach E., Magre S., Demassay Y., and Pujol J.F. Evidence for the localization of 5HT1-A binding sites on serotonin containing neurons in the raphe dorsalis and raphe centralis nuclei of the rat brain. Neurochem. Int. 7 (1985) 1061-1072
78. Wendland J.R., Martin B.J., Kruse M.R., Lesch K.P., and Murphy D.L. Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531. Mol. Psychiatry 11 3 (2006) 224-226
79. Whale R., Quested D.J., Laver D., Harrison P.J., and Cowen P.J. Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine. Psychopharmacology (Berl) 150 1 (2000) 120-122
80. Willeit M., Stastny J., Pirker W., Praschak-Rieder N., Neumeister A., Asenbaum S., Tauscher J., Fuchs K., Sieghart W., Hornik K., Aschauer H.N., Brücke T., and Kasper S. No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism. Biol. Psychiatry 50 1 (2001) 8-12
81. Williams R.B., Marchuk D.A., Gadde K.M., Barefoot J.C., Grichnik K., Helms M.J., Kuhn C.M., Lewis J.G., Schanberg S.M., Stafford-Smith M., Suarez E.C., Clary G.L., Svenson I.K., and Siegler I.C. Serotonin-related gene polymorphisms and central nervous system serotonin function. Neuropsychopharmacology 28 3 (2003) 533-541
82. Zalsman G., Anderson G.M., Peskin M., Frisch A., King R.A., Vekslerchik M., Sommerfeld E., Michaelovsky E., Sher L., Weizman A., and Apter A. Relationships between serotonin transporter promoter polymorphism, platelet serotonin transporter binding and clinical phenotype in suicidal and non-suicidal adolescent inpatients. J. Neural Transm. 112 2 (2005) 309-315
83. Zalsman G., Huang Y.Y., Oquendo M.A., Burke A.K., Hu X.Z., Brent D.A., Ellis S.P., Goldman D., and Mann J.J. Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression. Am. J. Psychiatry 163 9 (2006) 1588-1593
84. Zimmer L., Mauger G., Le Bars D., Bonmarchand G., Luxen A., and Pujol J.F. Effect of endogenous serotonin on the binding of the 5-hT1A PET ligand 18F-MPPF in the rat hippocampus: kinetic beta measurements combined with microdialysis. J. Neurochem. 80 2 (2002) 278-286
85. Zhuang Z.P., Kung M.P., Chumpradit S., Mu M., and Kung H.F. Derivatives of 4-(2′-methoxyphenyl)-1-[2′-(N-2″-pyridinyl-p-iodobenza mido)ethyl]pipera zine (p-MPPI) as 5-HT1A ligands. J. Med. Chem. 37 26 (1994) 4572-4575